C - Chemistry – Metallurgy – 07 – D
Patent
C - Chemistry, Metallurgy
07
D
C07D 217/24 (2006.01) A61K 31/472 (2006.01) A61K 31/4725 (2006.01) A61P 9/00 (2006.01) A61P 25/00 (2006.01) A61P 29/00 (2006.01) A61P 35/00 (2006.01) C07D 401/04 (2006.01)
Patent
CA 2762226
There are provided substituted isoquinolin-1(2H)-one derivatives which selectively inhibit the activity of poly (ADP- ribose) polymerase PARP-1 with respect to poly (ADP-ribose) polymerase PARP-2. The compounds of the present invention are therefore useful in treating diseases such as cancer, cardiovascular diseases, central nervous system injury and different forms of inflammation. The present invention also provides methods for preparing these compounds, pharmaceutical compositions comprising these compounds, and methods of treating diseases utilizing pharmaceutical compositions comprising these compounds. A screening method for the identification of compounds capable of binding several PARP proteins, as well the probes used in such method, are further objects of the invention.
L'invention concerne des dérivés isoquinoléin-1(2H)-one substitués inhibant sélectivement l'activité de la poly(ADP-ribose)polymérase PARP-1 par rapport à la poly(ADP-ribose)polymérase PARP-2. Les composés de l'invention sont donc utiles dans le traitement de maladies telles que le cancer, les maladies cardio-vasculaires, la lésion du système nerveux et différentes formes d'inflammation. L'invention porte également sur des méthodes de préparation de ces composés, sur des compositions pharmaceutiques comprenant lesdits composés, sur des méthodes de traitement de maladies au moyen de compositions pharmaceutiques comprenant lesdits composés. Une méthode de criblage pour l'identification de composés capables de fixer plusieurs protéines PARP ainsi que les sondes utilisées dans ladite méthode, sont également décrites.
Bertrand Jay Aaron
Cervi Giovanni
Forte Barbara
Lupi Rosita
Montagnoli Alessia
Nerviano Medical Sciences S.r.l.
Smart & Biggar
LandOfFree
Isoquinolin-1 (2h) -one derivatives as parp-1 inhibitors does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Isoquinolin-1 (2h) -one derivatives as parp-1 inhibitors, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Isoquinolin-1 (2h) -one derivatives as parp-1 inhibitors will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1416520